Merck & Co. Stock News

The U.S. Food and Drug Administration will send out around 100 cease-and-desist enforcement notices and thousands of letters warning pharmaceutical companies that direct-to-consumer ads must comply with regulations that are already on the books, senior administration officials said on Tuesday.

Merck & Co., Inc. (NYSE:MRK ) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 2:35 PM EDT Company Participants Robert Davis - Chairman, President & CEO Eliav Barr - Chief Medical Officer & Head of Global Clinical Development of Merck Research Laboratories Conference Call Participants Terence Flynn - Morgan Stanley, Research Division Presentation Terence Flynn Equity An...

5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 9% (Sept. 2025)

Verizon stands out as the only Dow stock meeting the 'dogcatcher' ideal: annual dividends from $1K invested exceed its share price and are well-covered. Analyst forecasts suggest top Dow Dogs could deliver 13-31% net gains by September 2026, with an average 19.4% return and lower-than-market volatility. Most Dow dividend stocks remain too expensive relative to their yields; market corrections o...

Merck & Co., Inc. (NYSE:MRK ) Wells Fargo 20th Annual Healthcare Conference 2025 September 4, 2025 11:50 AM EDT Company Participants Eliav Barr - Chief Medical Officer & Head of Global Clinical Development of Merck Research Laboratories Caroline Litchfield - Executive VP & CFO Conference Call Participants Mohit Bansal - Wells Fargo Securities, LLC, Research Division Presentation Mohit Bansal Se...

BEIJING--(BUSINESS WIRE)-- #AntibodyDrugDiscovery--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies and Merck, a leading science and technology company, have entered into an evaluation and option agreement to advance the development of antib...

Global drugmakers are scrambling to shore up their U.S. manufacturing capacity and domestic inventory as the Trump administration weighs hefty tariffs on pharmaceutical imports into the country.

"Dogs of the Dow" is a classic investment strategy. The idea is to find top-tier companies whose stocks are trading at unusually low prices, presumably for temporary reasons.